High-dose vitamin C (ascorbic acid) given through an IV behaves very differently from a vitamin pill. At low oral doses it works as an antioxidant. At pharmacologic IV doses it produces hydrogen peroxide in the fluid around cells, which can act on certain cancer cells and pathogens that lack the enzymes to clear it. The dose changes the drug.
Why the Dose Changes the Mechanism
At nutritional doses by mouth, vitamin C is an antioxidant. At pharmacologic doses through an IV, it acts as a pro-oxidant by generating small amounts of hydrogen peroxide in the fluid around your cells. Understanding the difference is the key to using this therapy thoughtfully.
Most people think of vitamin C as immune support during a cold. In Medicine 3.0, we view it through a metabolic lens, as a possible oxidative therapy.
This is not magic. It is mechanism-based pharmacology, championed by researchers at the National Institutes of Health (NIH). The same molecule changes function based on the concentration we reach in the bloodstream.
What Did the NIH Discover About Vitamin C Pharmacology?
Dr. Mark Levine and colleagues at the NIH showed that the route of administration changes the drug entirely.
- Oral capsules. Your gut acts as a strict gatekeeper. You can only reach about 200 µmol/L in the blood, no matter how many pills you take. At this level vitamin C works as an antioxidant.
- Intravenous (IV). By skipping the gut, we can drive blood levels up to 20,000 µmol/L. At that saturation, vitamin C flips to a pro-oxidant state.
- The reaction. In the interstitial fluid (the watery space between cells), high-dose vitamin C reacts with metal ions to make hydrogen peroxide (H2O2).
- The target. Healthy cells have a strong enzyme called catalase that neutralizes peroxide instantly. Many cancer cells and certain pathogens have low catalase. They cannot clear the peroxide and undergo oxidative stress.
It works as a selective stressor, hitting dysfunctional cells while sparing healthy tissue.
When Do We Use High-Dose IV Vitamin C?
We use high-dose IV C for two main situations.
- Adjunct cancer care. As detailed in our Integrative Cancer Care page, we use 50 to 75 gram infusions to add metabolic stress on tumor environments while supporting overall resilience. This is not a stand-alone cancer treatment.
- Acute viral defense. For high viral loads (COVID, flu, mono), 25 gram infusions create an oxidative environment that is less friendly to viral replication.
How Do Different Forms of Vitamin C Compare?
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can actually follow.
You need to be strategic. Even "liposomal C" cannot reach pharmacologic levels.
| Form | Blood Level | Use Case |
|---|---|---|
| Oral ascorbic acid | Low (about 80 µM). | Preventing deficiency, basic antioxidant support. |
| Liposomal C | Moderate (about 200 µM). | Better absorption, supports skin and general immunity. |
| IV Vitamin C | Pharmacologic (over 10,000 µM). | Targeted oxidative effect, acute viral support. |
Guidance from the Clinic
My perspective. In my experience, patients often assume more pills equals more benefit. Physiology has limits. With vitamin C, we are not topping off a tank, we are changing the fuel mixture for a specific metabolic outcome.
> "Dr. Ash, can I just take more pills?"
This is the most common question I hear. The short answer is "your gut will not let you."
Bowel tolerance for vitamin C is usually 5 to 10 grams before significant GI distress (loose stools, cramping). To achieve the oxidative effect we see in the literature, you need 50 to 100 grams. The only way to bypass the gut gatekeeper is through the vein.
Actionable Steps in Philly
How we integrate this into a demanding lifestyle.
- Pre-flight drip. For patients who travel frequently for work, an IV C (15 to 25 grams) before a long-haul flight supports resilience against the typical "airplane cold."
- Cancer adjunct planning. If you are managing a diagnosis, the timing matters. High-dose C must be spaced away from certain chemotherapies (such as methotrexate) to avoid interference. We coordinate directly with your oncologist.
- Always check G6PD first. Before we give a high-dose IV C, we run a blood test for G6PD deficiency (a genetic enzyme deficiency that affects red blood cells). In G6PD-deficient patients, high-dose C can rupture red blood cells. We measure, we do not guess.
- Viral defense plan. For acute infections or lingering symptoms (COVID, Epstein-Barr, Lyme), 25 to 50 gram infusions may support the immune response.
Focus on function.
Scientific References
- Chen Q, Levine M, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008.
- Levine M, et al. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011.
- Ma Y, et al. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer. Sci Transl Med. 2014.
- Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004.
- Carr AC, Cook J. Intravenous vitamin C for cancer therapy: identifying the current gaps in our knowledge. Front Physiol. 2018.
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.
